Pivotal Trial in Canine Elbow Arthritis Now 25% Enrolled
Today R-NAV enrolled our 12th subject in a pivotal trial for the treatment of canine elbow osteoarthritis. The trial now is 25% enrolled.
Today R-NAV enrolled our 12th subject in a pivotal trial for the treatment of canine elbow osteoarthritis. The trial now is 25% enrolled.